Logo
A

Aerpio Pharmaceuticals

7 employees

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Therapeutics
Health Care

Date founded

2011

Funding rounds raised

Total raised

$40M

from 16 investors over 16 rounds

A

Aerpio Pharmaceuticals raised $40M on March 16, 2017

Investors: Kearny Venture Partners, OrbiMed Advisors, Athenian Venture Partners, Venture Investors and Triathlon Medical Ventures

A

Aerpio Pharmaceuticals raised undisclosed on October 28, 2016

Investors: Athenian Venture Partners

A

Aerpio Pharmaceuticals raised $22M on April 23, 2014

Investors: Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners and OrbiMed Advisors

A

Aerpio Pharmaceuticals raised $36M on November 6, 2013

Investors: CincyTech USA, Triathlon Medical Ventures, Venture Investors, Athenian Venture Partners and Kearny Venture Partners

A

Aerpio Pharmaceuticals raised $5M on January 5, 2012

Investors: Venture Investors

FAQ